Imperial Ginseng Products Ltd.
IGPFF
$0.0605
$0.010621.24%
| Weiss Ratings | IGPFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | C | |||
| Rating Factors | IGPFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | IGPFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.65 | |||
| Price History | IGPFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -47.89% | |||
| 2-Year Total Return | -2,644.24% | |||
| 3-Year Total Return | -2,629.42% | |||
| 5-Year Total Return | -2,397.53% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 21.24% | |||
| Price | IGPFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.06 | |||
| 52-Week Low Price | $0.05 | |||
| 52-Week Low Price (Date) | May 01, 2024 | |||
| 52-Week High Price (Date) | Jul 22, 2024 | |||
| Valuation | IGPFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 424.04K | |||
| Enterprise Value | 298.88K | |||
| Price/Earnings (TTM) | 3.88 | |||
| Earnings Per Share (TTM) | 0.02 | |||
| Earnings Per Share Growth | -94.24% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 2.88 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.06 | |||
| Enterprise Value/EBITDA (TTM) | -6.29 | |||
| Enterprise Value/EBIT | -1.72 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | IGPFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 7.65M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $1.67 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | 9,178.05% | |||
| Dividend Per Share (Most Recent) | $1.67 | |||
| Company Info | IGPFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 234-479-0909 | |||
| Address | 1030 West Georgia Street Vancouver, BC V6E 2Y3 | |||
| Website | www.imperialginseng.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | IGPFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | IGPFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -1.54% | |||
| Return on Equity | 59.84% | |||
| Income Statement | IGPFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -45.70K | |||
| EBIT (TTM) | -167.50K | |||
| Net Income (TTM) | 137.10K | |||
| Net Income Avl. to Common (TTM) | 137.10K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -170.26% | |||
| EPS Diluted (TTM) | 0.02 | |||
| EPS Diluted Growth (Q YOY) | -171.11% | |||
| Balance Sheet | IGPFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 125.60K | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 188.50K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 160.80K | |||
| Current Ratio (Q) | 6.781 | |||
| Book Value Per Share (Q) | $0.02 | |||
| Total Assets (Q) | 188.50K | |||
| Total Current Liabilities (Q) | 27.80K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 27.80K | |||
| Total Common Equity (Q) | 160.80K | |||
| Cash Flow | IGPFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 0.00 | |||
| Cash from Financing (TTM) | -12.57M | |||
| Net Change in Cash (TTM) | -12.61M | |||
| Levered Free Cash Flow (TTM) | -12.60M | |||
| Cash from Operations (TTM) | -43.20K | |||
